文献速递肾小球疾病

局灶节段性肾小球硬化患者肾脏与外周血细胞中JAK-STAT信号激活

JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis.
PubMed 文献 · Kidney Int · 2018-08-06

该研究在106例经活检证实的FSGS患者与47例健康对照中,评估外周血单个核细胞和肾脏JAK-STAT活性。结果显示FSGS患者外周pSTAT产生基线上调且对细胞因子应答储备有限,肾脏JAK-STAT组分染色增加,转录组证据显示肾小球和肾小管间质pSTAT1和pSTAT3增加,部分变化与蛋白尿缓解及疾病进展相关。

要点

  • FSGS患者外周免疫细胞JAK-STAT信号基线激活且细胞因子应答储备受限。
  • FSGS肾脏肾小球和肾小管间质中pSTAT1和pSTAT3增加。
  • 部分JAK-STAT变化与蛋白尿缓解可能性和疾病进展相关。

核心结论

  • FSGS患者存在JAK-STAT信号改变,表现为外周免疫细胞激活、肾脏转录本增加及肾脏活化蛋白增加,支持免疫激活参与该病并提示JAK-STAT通路为潜在治疗靶点。

研究设计与样本

  • 研究纳入106例经活检证实的FSGS患者与47例健康对照个体,评估外周血单个核细胞和肾脏JAK-STAT活性。

主要发现

  • FSGS患者外周血单个核细胞基线pSTAT产生上调,且对多种细胞因子应答储备有限。
  • 显微镜检查发现FSGS中JAK-STAT系统组分染色增加。
  • 转录组证据显示FSGS肾脏肾小球和肾小管间质切片中pSTAT1和pSTAT3增加。
  • 部分JAK-STAT变化与蛋白尿缓解可能性和疾病进展相关。

临床怎么用

  • JAK-STAT通路可作为FSGS潜在治疗靶点,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Focal segmental glomerular sclerosis (FSGS) is a devastating disease with limited treatment options and poor prognosis. Activated JAK-STAT signaling has been implicated in other kidney diseases. Since new technologies allow us to better evaluate changes in systemic and renal JAK-STAT activity as it relates to kidney function, we examined this in 106 patients with biopsy-proven FSGS compared to 47 healthy control individuals. Peripheral immune function was assessed in peripheral blood mononuclear cells by phosphoflow studies before and after cytokine stimulation. Kidney JAK-STAT activity was measured by immunofluorescence and by transcriptomics. A STAT1 activity score was calculated by evaluating message status of downstream targets of pSTAT 1. Peripheral blood mononuclear cells were found to be upregulated in terms of pSTAT production at baseline in FSGS and to have limited reserve to respond to various cytokines. Increased staining for components of the JAK-STAT system in FSGS by microscopy was found. Furthermore, we found transcriptomic evidence for activation of JAK-STAT that increased pSTAT 1 and pSTAT 3 in glomerular and tubulointerstitial sections of the kidney. Some of these changes were associated with the likelihood of remission of proteinuria and progression of disease. JAK-STAT signaling is altered in patients with FSGS as compared to healthy controls with activated peripheral immune cells, increased message in the kidney and increased activated proteins in the kidney. Thus, our findings support immune activation in this disease and point to the JAK-STAT pathway as a potential target for treatment of FSGS.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Tao J, Mariani L, Eddy S, et al. JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis. Kidney Int. 2018. PMID: 30093081. doi:10.1016/j.kint.2018.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。